Medical AI

Kythera Labs and Databricks are tackling one of healthcare's biggest hurdles: translating complex clinical notes into AI-ready data. Here's why it matters.

Neurophet's AI software, now at Raffles Medical, analyzes brain MRIs in minutes, offering a powerful new weapon in the fight against dementia and MS in Asia.

Active Care Group's new high-tech hospital isn't just about patient care. It's a strategic play where private equity, AI, and a hallowed legacy converge.

Alleva Intelligence aims to unify clinical and operational AI, but can a single ecosystem overcome the deep-seated challenges of a sector in crisis?

An Oxford startup's AI-powered blood test can detect cancer and heart disease in dogs from a single sample, heralding a shift from reactive to proactive care.

A new company is launching an AI-powered specialty to detect cancer before it forms. But can this personalized, oncologist-led model overcome hurdles of cost and access?

The global MRI market is shifting from a hardware race to a software game. AI, low-helium systems, and workflow automation are the new keys to success.

The Association for Diagnostics & Laboratory Medicine's new leadership, led by Dr. Christina Lockwood, signals a decisive move to tackle healthcare's biggest challenges.

A new partnership between Harvard researchers and AI firm HiLabs aims to unmask the 'ghost networks' in Medicare Advantage, a crisis blocking care for millions.

GuideAI Health's new AI platform just hit the public market. It promises to find hidden vascular disease in routine scans, but can it navigate the risks?

An award for an AI search tool seems routine, but Ask Ella signals a deeper rewiring of the life sciences industry, turning data drudgery into strategic speed.

A new deal in Israel signals a shift from noisy, ineffective warnings to precise, life-saving insights. Is this the future of personalized medication safety?

The animal health leader faces scrutiny in its Q2 earnings call after a rocky first quarter. All eyes are on its strategy to balance market pressures with future-focused bets.

By combining vast datasets with patient-driven advocacy, a new alliance offers hope for angiosarcoma patients and a new model for rare disease research.

A new wearable from NeuroLife promises to personalize stroke and spinal cord injury rehab. Can this non-invasive sleeve bridge the gap in accessible care?

A new MS center in Lone Tree isn't just an expansion; it's a strategic play, blending clinical expertise with a powerful new operational model for growth.

Health Union's new AI suite aims to connect patients and doctors. But can algorithms truly capture the human element of care without compromising privacy?

Carolyn Starrett's appointment to the NeoGenomics board signals a major push to integrate AI and real-world data into the core of cancer diagnostics.

Aidoc's 'First Read' AI has earned a coveted FDA Breakthrough designation, promising to ease radiologist workload. But can an algorithm be trusted with your health?